# A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects

> **NCT05362695** · PHASE1 · COMPLETED · sponsor: **Ironwood Pharmaceuticals, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** IW-3300
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05362695
- **Lead sponsor:** Ironwood Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-17
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-07-13
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362695, "A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05362695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*